Jianming Guo

10PUBLICATIONS
33CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 08, 2026
A disease-centric vision-language foundation model for precision oncology in kidney cancer.

|Jun 05, 2026
FN1+ macrophages fuel aggressive sarcomatoid differentiation and immunotherapy refractory outcome in clear cell renal cell carcinoma.

|Feb 24, 2026
Lactate-Driven IL8+ Tumor-Associated Macrophages Mediate Immunosuppression and Resistance to Immunotherapy in Clear-Cell Renal Cell Carcinoma.

Yu Dong, Wenbin Jiang, Youqi Qiu

|Jul 18, 2025
SPP1+ Tumor-Associated Macrophages Drive Immunotherapy Resistance via CD8+ T-cell Dysfunction in Clear-Cell Renal Cell Carcinoma.

Wenbin Jiang, Li Liu, Ziyang Xu

|Feb 06, 2025
Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses.

Ying Xiong, Linpeng Yao, Jinglai Lin

|Mar 28, 2024
Effect of galectin-1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma.

Jiajun Wang, Sihong Zhang, Ying Wang

Pageof 2

Frequent Collaborators

3 joint publications

Siyuan Dai

3 joint publications

Jiejie Xu

2 joint publications

Ziyang Xu

2 joint publications

Li Liu